Table 4.
Median of the JADAS10 parameters AJC, physician’s VAS, parent/patient VAS and ESR in patient classified as CID, LDA, MDA and HDA according to cut-off values presented in the present study and those proposed earlier by Consolaro et al12 18 19
| Oligoarticular disease | AJC median (range) | Parent/patient VAS median (range) | Physician’s VAS median (range) | ESR median (range) |
| CID | ||||
| JADAS10 ≤0.5 (n=77) | 0 (0) | 0.0 (0.0–0.5) | 0.0 (0.0–1.0) | 5 (1–20) |
| JADAS10 ≤1.018 (n=89) | 0 (0–1) | 0.0 (0.0–1.0) | 0.0 (0.0–1.0) | 5 (1–20) |
| JADAS10 ≤1.519 (n=99) | 0 (0–1) | 0.0 (0.0–1.5) | 0.0 (0.0–1.0) | 5 (1–20) |
| LDA | ||||
| JADAS10 0.6–3.8 (n=60) | 0 (0–2) | 0.0 (0.0–3.6) | 0.5 (0.0–3.0) | 4 (2–21) |
| JADAS10 1.1–2.018 (n=17) | 0 (0–1) | 1.0 (0.0–2.0) | 0.2 (0.0–1.0) | 4 (2–11) |
| JADAS10 1.6–3.919 (n=38) | 0 (0–2) | 1.5 (0.0–3.6) | 0.8 (0.0–3.0) | 4 (2–21) |
| MDA | ||||
| JADAS10 3.9–6.6 (n=28) | 1 (0–3) | 2.1 (0.0–5.4) | 1.6 (0.0–3.0) | 8 (2–31) |
| JADAS10 2.1–4.218 (n=35) | 0 (0–2) | 1.6 (0.0–4.0) | 1 (0.0–3.0) | 4 (2–21) |
| JADAS10 4.0–16.419 (n=46) | 1 (0–3) | 3.2 (0.0–10.0) | 1.9 (0.0–5.0) | 5 (2–31) |
| HDA | ||||
| JADAS10 >6.6 (n=18) | 1 (0–3) | 5.2 (2.6–10.0) | 2.0 (1.0–5.0) | 4 (2–25) |
| JADAS10 >4.218 (n=42) | 1 (0–3) | 3.6 (0.0–10.0) | 1.9 (0.0–5.0) | 5 (2–31) |
| JADAS10 >16.419 (n=0) | ||||
| Polyarticular disease | ||||
| CID | ||||
| JADAS10 ≤0.7 (n=52) | 0 (0) | 0.0 (0.0–0.6) | 0.0 (0.0–1.0) | 5 (1–18) |
| JADAS10 ≤1.018 (n=64) | 0 (0) | 0.0 (0.0–1.0) | 0.0 (0.0–1.0) | 5 (1–22) |
| JADAS10 ≤2.619 (n=89) | 0 (0–1) | 0.0 (0.0–2.6) | 0.0 (0.0–2.0) | 5 (1–33) |
| LDA | ||||
| JADAS10 0.8–3.9 (n=60) | 0 (0–3) | 1.0 (0.0–4.0) | 0.5 (0.0–2.0) | 5 (1–33) |
| JADAS10 1.1–3.818 (n=39) | 0 (0–2) | 1.4 (0.0–3.7) | 0.5 (0.0–2.0) | 5 (1–33) |
| JADAS10 2.7–5.119 (n=23) | 1 (0–3) | 1.7 (0.0–4.4) | 1.0 (0.0–2.0) | 5 (2–21) |
| MDA10 | ||||
| JADAS10 4.0–15.2 (n=32) | 3 (0–8) | 3.8 (0.0–7.8) | 2.5 (0.0–4.0) | 8 (1–33) |
| JADAS10 3.9–10.518 (n=34) | 2 (0–6) | 2.6 (0.0–7.8) | 2.0 (0.0–4.0) | 7 (1–33) |
| JADAS10 5.1–18.919 (n=37) | 3 (0–10) | 4.0 (0.0–8.5) | 2.5 (0.0–5.0) | 1 (1–44) |
| HDA13 | ||||
| JADAS10 >15.2 (n=10) | 10 (3–15) | 4.6 (2.5–8.5) | 4.2 (3.0–8.0) | 8 (2–62) |
| JADAS10 >10.512 18 (n=17) | 7 (2–15) | 4.3 (1.5–8.5) | 3.0 (2.0–8.0) | 7 (2–62) |
| JADAS10 >18.919 (n=5) | 10 (7–15) | 4.3 (2.6–7.6) | 6.5 (3.0–8.0) | 16 (3–62) |
AJC, active joint count; CID, clinically inactive disease; ESR, erythrocyte sedimentation rate; HDA, high disease activity; JADAS, Juvenile Arthritis Disease Activity Score; LDA, low disease activity; MDA, moderate disease activity; VAS, visual analogue scale.